These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24448106)

  • 1. Mood disorders in midlife women: understanding the critical window and its clinical implications.
    Soares CN
    Menopause; 2014 Feb; 21(2):198-206. PubMed ID: 24448106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities to manage depression during the menopausal transition and beyond.
    Soares CN; Frey BN
    Psychiatr Clin North Am; 2010 Jun; 33(2):295-308. PubMed ID: 20385338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates.
    Frey BN; Lord C; Soares CN
    Menopause Int; 2008 Sep; 14(3):123-8. PubMed ID: 18714078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.
    Soares CN
    Drugs Aging; 2013 Sep; 30(9):677-85. PubMed ID: 23801148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and the menopause: why antidepressants are not enough?
    Graziottin A; Serafini A
    Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of mood disorders during the menopausal transition.
    Cohen LS; Soares CN; Joffe H
    Am J Med; 2005 Dec; 118 Suppl 12B():93-7. PubMed ID: 16414333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal transition, mood, and cognition: an integrated view to close the gaps.
    Soares CN; Maki PM
    Menopause; 2010 Jul; 17(4):812-4. PubMed ID: 20616667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.
    Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN
    J Womens Health (Larchmt); 2019 Feb; 28(2):117-134. PubMed ID: 30182804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
    Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN;
    Menopause; 2018 Oct; 25(10):1069-1085. PubMed ID: 30179986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Series overview and introduction.
    Alexander JL; Dennerstein L
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S3-6. PubMed ID: 18039066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and Menopause: An Update on Current Knowledge and Clinical Management for this Critical Window.
    Soares CN
    Med Clin North Am; 2019 Jul; 103(4):651-667. PubMed ID: 31078198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study.
    Heinrich AB; Wolf OT
    Neuropsychobiology; 2005; 52(1):17-23. PubMed ID: 15942259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of hormones and menopausal status with depressed mood in women with no history of depression.
    Freeman EW; Sammel MD; Lin H; Nelson DB
    Arch Gen Psychiatry; 2006 Apr; 63(4):375-82. PubMed ID: 16585466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study.
    Demetrio FN; Rennó J; Gianfaldoni A; Gonçalves M; Halbe HW; Filho AH; Gorenstein C
    Arch Womens Ment Health; 2011 Dec; 14(6):479-86. PubMed ID: 22016254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and management of depressive and anxiety symptoms in midlife.
    Hickey M; Bryant C; Judd F
    Climacteric; 2012 Feb; 15(1):3-9. PubMed ID: 22132727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study.
    Woods NF; Mitchell ES; Adams C
    Menopause; 2000; 7(4):257-65. PubMed ID: 10914619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultural/ethnic differences in the prevalence of depressive symptoms among middle-aged women in Israel: the Women's Health at Midlife Study.
    Blumstein T; Benyamini Y; Hourvitz A; Boyko V; Lerner-Geva L
    Menopause; 2012 Dec; 19(12):1309-21. PubMed ID: 22760088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive disorders and the menopause transition.
    Llaneza P; García-Portilla MP; Llaneza-Suárez D; Armott B; Pérez-López FR
    Maturitas; 2012 Feb; 71(2):120-30. PubMed ID: 22196311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.